Drugs / GIP
last change Nov 2022 re-read 3 minutes ago

GIP

Developed for
hypoglycemia · type 1 diabetes mellitus

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT03734718 Comparator Jun → Dec 2019 hypoglycemia, type 1 diabetes mellitus Steno Diabetes Center Copenhagen Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as GIP ClinicalTrials.gov intervention name — accepted as the source's own label NCT03734718 ↗
Route Subcutaneous “6-day continuous subcutaneous infusion with GIP” PMID 36111559 ↗ Nov 2022